SEC 13F Intelligence

Managers / Q3 2022 · view latest →

Valliance Asset Management Ltd

CIK 0001846639 · 16/F, 8 QUEEN'S ROAD, CENTRAL, K3, 000000 · 852 35657001

Reported Value
$36M
Q3 2022
Positions
6
Filings on Record
22
2019–present window
Filed
Nov 9, 2022
original filing

Summary

Valliance Asset Management Ltd reported $36M in U.S.-listed holdings across 6 positions for Q3 2022.

The portfolio is heavily concentrated: Summit Healthcre Acquistn alone accounts for 27.4% of reported value.

Compared with Q2 2022, the fund opened 4 new positions and exited 1.

Portfolio Metrics

Turnover
+22.5%
vs prior filed quarter
Largest Position
+27.4%
Summit Healthcre Acquistn
New / Exited
4 / 1
positions this quarter

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’20: $47MQ4 ’20Q1 ’21: $8MQ2 ’21: $23MQ3 ’21: $99MQ3 ’21Q4 ’21: $41MQ1 ’22: $18MQ2 ’22: $24MQ2 ’22Q3 ’22: $36MQ4 ’22: $71MQ1 ’23: $56MQ1 ’23Q2 ’23: $6MQ3 ’23: $27MQ4 ’23: $3MQ4 ’23Q1 ’24: $41MQ2 ’24: $66MQ3 ’24: $82MQ3 ’24Q4 ’24: $56MQ1 ’25: $44MQ2 ’25: $13MQ2 ’25Q3 ’25: $13MQ4 ’25: $240MQ1 ’26: $122MQ1 ’26filingsflow.com

Portfolio Composition

By security type
Other: 50.2%Common Stock: 49.8%
  • Other · 50.2% · $18M
  • Common Stock · 49.8% · $18M

Quarter-over-Quarter Changes full breakdown →

vs Q2 2022 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
NVDANVIDIA CORPORATIONNEW+68.1K68.1K+$8M$8M
ORCLORACLE CORPNEW+123.8K123.8K+$8M$8M
NOWSERVICENOW INCNEW+5.4K5.4K+$2M$2M
ATLASSIAN CORP PLCNEW+1.1K1.1K+$226,000$226,000
NTESNETEASE INCSOLD OUT−72.7K0−$7M$0
SUMMIT HEALTHCRE ACQUISTN COHELD+01.00M+$110,000$10M
HH&L ACQUISITION COHELD+0800.0K+$64,000$8M

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q3 2022

6 positions
Export to Excel
#IssuerClass% PortfolioValue ↓Shares
1SUMMIT HEALTHCRE ACQUISTN COUNIT 06/03/202627.45%$10M1.00M
2NVDANVIDIA CORPORATIONhistory →COM23.01%$8M68.1K
3HH&L ACQUISITION COUNIT 99/99/999922.16%$8M800.0K
4ORCLORACLE CORPhistory →COM21.05%$8M123.8K
5NOWSERVICENOW INChistory →COM5.70%$2M5.4K
6ATLASSIAN CORP PLCCL A0.63%$226,0001.1K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q1 2026$122M8May 12, 202613F-HRchanges · EDGAR ↗
Q4 2025$240M11Feb 13, 202613F-HRchanges · EDGAR ↗
Q3 2025$13M1Oct 22, 202513F-HRchanges · EDGAR ↗
Q2 2025$13M5Jul 31, 202513F-HRchanges · EDGAR ↗
Q1 2025$44M25May 8, 202513F-HRchanges · EDGAR ↗
Q4 2024$56M18Feb 4, 202513F-HRchanges · EDGAR ↗
Q3 2024$82M7Oct 31, 202413F-HRchanges · EDGAR ↗
Q2 2024$66M15Aug 7, 202413F-HRchanges · EDGAR ↗
Q1 2024$41M8May 7, 202413F-HRchanges · EDGAR ↗
Q4 2023$3M6Jan 31, 202413F-HRchanges · EDGAR ↗
Q3 2023$27M14Oct 27, 202313F-HRchanges · EDGAR ↗
Q2 2023$6M4Jul 26, 202313F-HRchanges · EDGAR ↗
Q1 2023$56M9May 10, 202313F-HRchanges · EDGAR ↗
Q4 2022$71M8Feb 7, 202313F-HRchanges · EDGAR ↗
Q3 2022$36M6Nov 9, 202213F-HRchanges · EDGAR ↗
Q2 2022$24M3Aug 10, 202213F-HRchanges · EDGAR ↗
Q1 2022$18M2Apr 25, 202213F-HRchanges · EDGAR ↗
Q4 2021$41M3Jan 28, 202213F-HRchanges · EDGAR ↗
Q3 2021$99M6Oct 27, 202113F-HRchanges · EDGAR ↗
Q2 2021$23M3Jul 28, 202113F-HRchanges · EDGAR ↗
Q1 2021$8M1May 5, 202113F-HRchanges · EDGAR ↗
Q4 2020$47M3Feb 18, 202113F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.